EPISODE · May 4, 2026 · 2 MIN
Bio-Rad Q2 2025: Strong Growth & Raised Guidance
from The Daily News Now! Business
Bio-Rads Q2 2025 earnings beat expectations with $652 million in sales, up 2.1% year-over-year, driven by strong process chromatography in life sciences. Operating margins hit 13.6% non-GAAP, despite headwinds. Life sciences saw a 4.7% increase, while diagnostics held steady. Consumables like droplet digital PCR showed high single-digit gains. The company raised full-year guidance, with process chromatography outlook at low double-digits and ddPCR mid-single-digit growth. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/764a6dd77084867b
NOW PLAYING
Bio-Rad Q2 2025: Strong Growth & Raised Guidance
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m